Unaudited Condensed Statements of Cash Flows (USD $)	3 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash Flows from operating activities
Net Loss	$ (822,649)	$ (702,718)
Changes in non cash working capital items:
Depreciation	863	572
Amortization	2,650	13,868
Amortization of deferred financing fees	7,292	3,581
Accretion on discount on convertible bond	374,767	76,701
Loss on derivative liability	255,281	293,171
Changes in Operating assets and liabilities:
Accounts receivable	(600)	(15,638)
Inventory	(7,467)	4,443
Prepaid expenses	21,500	32,006
Accounts payable	59,039	77,377
Accrued wages - Officers	28,724	52,661
Accrued expenses	37,176	33,748
Net cash used for operating activities	(43,424)	(130,228)
Cash Flows from investing activities
Patent acquisition costs	(6,032)	(2,779)
Property and equipment acquisition costs	0	(232)
Net cash used for investing activities	(6,032)	(3,011)
Cash flows from financing activities
Proceeds from notes	29,000	92,830
Net cash provided by financing activities	29,000	92,830
Net decrease in cash	(20,456)	(40,409)
Cash at beginning of the period	48,576	41,180
Cash at end of the period	28,120	771
Supplemental disclosures of noncash investing and financing activities and other cash flow information:
Short-term debt and accrued interest converted to common stock	192,060	50,730
Retirement of derivative liability - convertible debt	253,588	17,357
Issuance of derivative liability - convertible debt	50,594	151,592
Interest paid with cash	$ 0	$ 14,263